These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10912304)

  • 1. Sub-optimal ACE-inhibitor prescribing and increased all-cause mortality risk. A critical evaluation of routine clinical care.
    Hall A
    Int J Clin Pract Suppl; 2000 May; (110):23. PubMed ID: 10912304
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacoepidemiology of antihypertensive drugs in primary care setting of Bahrain between 1998 and 2000.
    Al Khaja KA; Sequeira RP
    Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):741-8. PubMed ID: 16342299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why aren't we using beta blockers after acute MI?
    Weichel AS
    Am Fam Physician; 2000 Oct; 62(8):1771-2. PubMed ID: 11057834
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug prescribing indicators in village health clinics across 10 provinces of Western China.
    Dong L; Yan H; Wang D
    Fam Pract; 2011 Feb; 28(1):63-7. PubMed ID: 20876222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
    Filippi A; D'Ambrosio G; Giustini SE; Pecchioli S; Mazzaglia G; Cricelli C
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary prevention following coronary artery bypass grafting has improved but remains sub-optimal: the need for targeted follow-up.
    Turley AJ; Roberts AP; Morley R; Thornley AR; Owens WA; de Belder MA
    Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):231-4. PubMed ID: 18234766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Warning about overconsumption of psychotropic drugs in adolescents].
    Hansen BB
    Soins Pediatr Pueric; 2005 Apr; (223):7. PubMed ID: 15869026
    [No Abstract]   [Full Text] [Related]  

  • 8. A slow trickledown. Data on efficacy of beta blockers belatedly spur use.
    Moore JD
    Mod Healthc; 1998 Sep; 28(37):70. PubMed ID: 10183097
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].
    Arós F; Loma-Osorio A; Vila J; López-Bescós L; Cuñat J; Rodríguez E; San José JM; Heras M; Marrugat J;
    Rev Esp Cardiol; 2006 Apr; 59(4):313-20. PubMed ID: 16709383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of drug use in Jordan using WHO prescribing indicators.
    Otoom S; Batieha A; Hadidi H; Hasan M; Al-Saudi K
    East Mediterr Health J; 2002; 8(4-5):537-43. PubMed ID: 15603035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Care of acute myocardial infarction in Oklahoma: an update from the Cooperative Cardiovascular Project.
    Bratzler DW; Oehlert WH; Walkingstick K; Murray CK; Shook C;
    J Okla State Med Assoc; 2001 Oct; 94(10):443-50. PubMed ID: 11641999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting costs by targeting prescribing practices.
    Edouard L; Rawson NS
    CMAJ; 1994 Jul; 151(1):14-5. PubMed ID: 8004553
    [No Abstract]   [Full Text] [Related]  

  • 13. Physician prescribing and the hippocratic oath.
    Mullins CD
    Clin Ther; 2005 May; 27(5):628-9. PubMed ID: 15978312
    [No Abstract]   [Full Text] [Related]  

  • 14. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary care prescribing patterns in Ireland after the publication of large hypertension trials.
    Kabir Z; Feely J; Bennett K
    Br J Clin Pharmacol; 2007 Sep; 64(3):381-5. PubMed ID: 17610535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?
    Hudson M; Richard H; Pilote L
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):773-85. PubMed ID: 17486661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of care of international and Canadian medical graduates in acute myocardial infarction.
    Ko DT; Austin PC; Chan BT; Tu JV
    Arch Intern Med; 2005 Feb; 165(4):458-63. PubMed ID: 15738378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription patterns of pharmacological agents for left ventricular systolic dysfunction among hemodialysis patients.
    Roy P; Bouchard J; Amyot R; Madore F
    Am J Kidney Dis; 2006 Oct; 48(4):645-51. PubMed ID: 16997061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Secondary medical prevention in patients with peripheral arterial disease.
    Schouten O; Welten GM; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):59-60. PubMed ID: 17719805
    [No Abstract]   [Full Text] [Related]  

  • 20. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.
    Gasse C; Jacobsen J; Larsen AC; Schmidt EB; Johannesen NL; Videbaek J; Sørensen HT; Johnsen SP
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):51-8. PubMed ID: 17923426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.